Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roselli

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Haematologica|December 11, 2013
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyPatrizia Ferroni, Silvia Riondino, Fiorella Guadagni, et al.
The International Journal of Biological Markers|March 12, 2019
Precision medicine in the ageing world: The role of biospecimen sciencesSilvia Riondino, Patrizia Ferroni, Mario Roselli, et al.
Critical Reviews in Oncology/Hematology|August 13, 2021
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attentionGiovanni Maria Iannantuono, Lidia Strigari, Mario Roselli, et al.
The Lancet. Haematology|September 3, 2018
Artificial intelligence for cancer-associated thrombosis risk assessmentPatrizia Ferroni, Mario Roselli, Fabio M Zanzotto, et al.
Current Medicinal Chemistry|October 21, 2016
Gender Differences in Cancer-associated Venous ThromboembolismSilvia Riondino, Fiorella Guadagni, Vincenzo Formica, et al.
Expert Opinion on Investigational Drugs|February 5, 2014
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approachesVittore Cereda, Vincenzo Formica, Gioia Massimiani, et al.
Expert Opinion on Investigational Drugs|April 11, 2015
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challengesVittore Cereda, Vincenzo Formica, Antonello Menghi, et al.
Endocrine-Related Cancer|May 18, 2016
Insulin resistance as a predictor of venous thromboembolism in breast cancerPatrizia Ferroni, Mario Roselli, Silvia Riondino, et al.
World Journal of Gastroenterology|September 26, 2014
Immune reaction and colorectal cancer: friends or foes?Vincenzo Formica, Vittore Cereda, Antonella Nardecchia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2010
Cardiac sarcomas: an updateAugusto Orlandi, Amedeo Ferlosio, Mario Roselli, et al.
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Haematologica|December 11, 2013
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyPatrizia Ferroni, Silvia Riondino, Fiorella Guadagni, et al.
The International Journal of Biological Markers|March 12, 2019
Precision medicine in the ageing world: The role of biospecimen sciencesSilvia Riondino, Patrizia Ferroni, Mario Roselli, et al.
Critical Reviews in Oncology/Hematology|August 13, 2021
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attentionGiovanni Maria Iannantuono, Lidia Strigari, Mario Roselli, et al.
The Lancet. Haematology|September 3, 2018
Artificial intelligence for cancer-associated thrombosis risk assessmentPatrizia Ferroni, Mario Roselli, Fabio M Zanzotto, et al.
Current Medicinal Chemistry|October 21, 2016
Gender Differences in Cancer-associated Venous ThromboembolismSilvia Riondino, Fiorella Guadagni, Vincenzo Formica, et al.
Expert Opinion on Investigational Drugs|February 5, 2014
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approachesVittore Cereda, Vincenzo Formica, Gioia Massimiani, et al.
Expert Opinion on Investigational Drugs|April 11, 2015
Kallikrein-related peptidases targeted therapies in prostate cancer: perspectives and challengesVittore Cereda, Vincenzo Formica, Antonello Menghi, et al.
Endocrine-Related Cancer|May 18, 2016
Insulin resistance as a predictor of venous thromboembolism in breast cancerPatrizia Ferroni, Mario Roselli, Silvia Riondino, et al.
World Journal of Gastroenterology|September 26, 2014
Immune reaction and colorectal cancer: friends or foes?Vincenzo Formica, Vittore Cereda, Antonella Nardecchia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2010
Cardiac sarcomas: an updateAugusto Orlandi, Amedeo Ferlosio, Mario Roselli, et al.
Pageof 17